Drug intelligence / Profile preview

ampicillin + penicillin

Development stage
Unknown
Lead developer
Meiji Seika Pharma
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

ampicillin + penicillin refers to a combination or alternative regimen of beta-lactam antibiotics used for the treatment of childhood pneumonia, particularly in resource-limited settings. Ampicillin is an aminopenicillin with broad-spectrum activity against Gram-positive and some Gram-negative bacteria, while penicillin (typically referring to benzylpenicillin or Penicillin G) is a narrow-spectrum antibiotic effective against Gram-positive organisms like *Streptococcus pneumoniae*. Both drugs function by binding to penicillin-binding proteins (PBPs), which are enzymes involved in the synthesis of peptidoglycan in the bacterial cell wall. By binding covalently and irreversibly to the active site of these enzymes, the antibiotics inhibit the transpeptidation reaction, preventing the cross-linking of peptidoglycan chains and leading to bacterial cell wall weakening and osmotic lysis. In the context of the ITIP3 (Innovative Treatments in Pneumonia) study led by Save the Children in Malawi, these parenteral antibiotics were evaluated as part of the standard of care for children aged 2 to 59 months presenting with pneumonia and high-risk comorbidities such as HIV, malnutrition, or malaria.

Other names
ampicillin/penicillinampicillin and penicillinampicillin + penicillin-Save the Children-pneumonia
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on ampicillin + penicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ampicillin + penicillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call